🇺🇸 FDA
Pipeline program

Exparel Injectable Product

402-C-123

Phase 1 small_molecule completed

Quick answer

Exparel Injectable Product for Breast Augmentation is a Phase 1 program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Pacira BioSciences
Indication
Breast Augmentation
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials